Yutrepia
NDC 72964-013, treprostinil, capsule, from Liquidia Technologies, Inc..
- Product NDC
- 72964-013
- Status
- Listed
- Labeler
- Liquidia Technologies, Inc.
- Dosage form
- CAPSULE
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213005
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72964-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TREPROSTINIL SODIUM79.5 ug/1
Pharmacologic classes
Prostacycline Vasodilator [EPC]; Prostaglandins I [CS]; Vasodilation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72964-013-01 | 72964001301 | 7 BLISTER PACK in 1 CARTON (72964-013-01) / 4 CAPSULE in 1 BLISTER PACK / 1 CAPSULE in 1 CAPSULE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e8f6d534-115c-440e-bdbb-b443a29bb468
Use it
Look up 72964-013 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72964-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72964-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.